imatinib mesylate has been researched along with Hematoma, Subdural, Intracranial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivan, ME; Komotar, RJ; Shah, AH; Theodotou, CB | 1 |
1 other study(ies) available for imatinib mesylate and Hematoma, Subdural, Intracranial
| Article | Year |
|---|---|
Subdural hematoma in a patient taking imatinib for GIST: a case report and discussion of risk with other chemotherapeutics.
Topics: Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hematoma, Subdural, Intracranial; Humans; Imatinib Mesylate; Middle Aged; Neoadjuvant Therapy; Risk | 2016 |